Oral Simufilam Slowed Cognitive Decline in a Randomized
Simufilam Slowed Cognitive Decline by 38% Versus Placebo Over 6 months in Patients with Mild-to-Moderate Alzheimer’s Disease.Drug Effects Favored Mild...
Source: globenewswire.com
Page 5 - Eric Schoen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Schoen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Schoen Today - Breaking & Trending Today
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer's Disease
Simufilam Slowed Cognitive Decline by 38% Versus Placebo Over 6 months in Patients with Mild-to-Moderate Alzheimer’s Disease.Drug Effects Favored Mild Alzheimer’s Disease.In Mild...
Source: marketscreener.com
New Research Shows Simufilam Suppresses Overactive mTOR
Overactive mTOR Plays a Key Role in Aging and Alzheimer’s Disease.Simufilam Suppresses Overactive mTOR, Suggesting a Beneficial Drug Effect.Research is Published in Frontiers in Aging, a Peer-reviewed Journal. AUSTIN, Texas, June 27, 2023 (GLOBE ...
Source: marketscreener.com
New Publication Highlights Basic Science Supporting Simufilam
Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting Simufilam. Published in Drug Development Research, a Peer-Reviewed Journal. AUSTIN, Texas,... | June 12, 2023
Source: marketscreener.com
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
AUSTIN, Texas, June 01, 2023 -- Cassava Sciences, Inc. , a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that its management has been invited to present... | June 1, 2023
Source: marketscreener.com